CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Ulipristal acetate

Last Updated: April 17, 2013
Result type: Reports
Project Number: SR0326-000
Product Line: Reimbursement Review

Generic Name: Ulipristal acetate

Brand Name: Fibristal

Manufacturer: Actavis Specialty Pharmaceuticals Co.

Therapeutic Area: Uterine fibroids

Indications: Uterine fibroids (signs and symptoms)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: November 15, 2013

Recommendation Type: List with criteria/condition